心肌病中的精准医学:进展和未来方向
Mahvish Mehdi1, Sushma Verma1, Bashir Ahmad Mir2
1Department of Personalized and Molecular Medicine, Era University, Lucknow, Uttar Pradesh, India.
Clinical genetics
|September 22, 2025
概括
精准医学通过整合遗传数据,生物标志物和成像来进行个性化诊断和治疗,彻底改变了心肌病治疗. 这种方法增强了风险分层,并改善了患有缩性,扩张性和其他心肌疾病的患者结果.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 个性化医疗是个性化的医疗.
背景情况:
- 心肌病包括一系列具有不同遗传基础的心肌疾病.
- 当前的诊断和治疗策略往往缺乏个性化,导致结果不理想.
- 精准医学的出现为管理这些复杂的疾病提供了范式的转变.
研究的目的:
- 审查精准医学在心肌病诊断,分类和治疗中的变革性作用.
- 探索基因分析,生物标志物和先进成像技术的整合.
- 讨论精准医学在主要心肌病亚型和儿科形式的应用.
主要方法:
- 综合文献综述,重点关注心肌病中的精密医学应用.
- 分析不同心肌病亚型的遗传驱动因素,包括线粒体突变.
- 对生物标志物和成像集成的评估,用于风险分层和突发心脏病死亡预测.
- 讨论动物模型和新兴的治疗策略,如基因编辑和药物基因组学.
主要成果:
- 精准医学通过整合遗传,分子和成像数据,使得定制的诊断和治疗成为可能.
- 基因分析确定了右心室缩性,扩张性,限制性和失律性心肌病的关键驱动因素.
- 结合生物标志物和心声回声学方法可以改善风险分层,特别是在心脏突然死亡方面.
- 动物模型对于将遗传发现转化为临床理解至关重要.
结论:
- 精准医学在推进心肌病治疗方面具有重大前景.
- 针对潜在的遗传原因,并根据个体情况量身定制治疗方法,可以使诊断更准确,结果更好.
- 这种方法正在为真正个性化的心血管护理铺平道路.
相关概念视频
Cardiomyopathy V: Interprofessional Care
339
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
Cardiomyopathy II: Dilated Cardiomyopathy
480
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Cardiomyopathy III: Hypertrophic Cardiomyopathy
414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Cardiomyopathy I: Introduction and Classification
514
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
514
Cardiomyopathy IV: Restrictive Cardiomyopathy
461
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
461
Myocarditis III: Medical Management
175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175


